Research in Social and Administrative Pharmacy
Volume 5, Issue 3 , Pages 286-297 , September 2009

Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines

  • Ebenezer Tetteh, B.Pharm., M.Sc.

      Affiliations

    • The author is a pharmacist with an MSc in Health Policy, Planning, and Financing from the London School of Economics and London School of Hygiene and Tropical Medicine. At the time of writing this article, the author worked at the Centre for Health Technology Evaluation of the National Institute for Health and Clinical Excellence, UK. The opinions expressed are entirely those of the author. No external funding was used in support of the article.
    • Corresponding Author InformationCorresponding author.

References 

  1. Money v mosquito: will an ambitious plan to subsidize antimalarial pills work?. November 3rd–9th issue Economist. 2007;385(8553):98
  2. RBM AMFm. (2007). Affordable Medicines Facility-malaria: technical design. Available at: http://rbm.who.int/partnership/tf/globalsubsidy/AMFmTechProposal.pdf. Accessed 03.01.08.
  3. Tetteh EK. Providing affordable essential medicines to African households: the missing policies and institutions for price containment. Soc Sci Med. 2008;66(3):569–581
  4. World Bank. (1994). Importance of pharmaceuti ls and essential drugprograms in Better Health for Africa: experience and lessons learned. Available at: www.worldbank.org Accessed 16.09.06.
  5. Enemark, U., Alban, A. and Vasquez, E.C.S. (2004). Purchasing pharmaceuticals. World Bank HNP discussion paper. Available at: www.worldbank.org Accessed 16.09.06.
  6. Guimier JM, Candau D, Garenne M, Teulieres L. Why drug prices are high in sub-Saharan Africa. Analysis of price structure: the case of Senegal. Santé. 2005;15(1):41–52
  7. WHO. World medicines situation. WHO/EDM/PAR/2004.5; 2004.
  8. Taylor D, Mrazek M, Mossialos E. Regulating pharmaceutical distribution and retail pharmacy in Europe. In:  Mossialos E,  Mrazek M,  Walley T editor. Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality. Maidenhead: Open University Press; 2004;p. 196–212
  9. Kaiser Family Foundation. (2005). Follow the pill: understanding the US commercial pharmaceutical supply chain. Available at: www.kff.org Accessed 18.04.06.
  10. Maiga FI, Haddad S, Fournier P, Gauvin L. Public and private sector responses to essential drugs: a multilevel analysis of drug prescription and selling practices in Mali. Soc Sci Med. 2003;57(5):937–948
  11. Quick JD, Boohene NA, Rankin J, Mbwasi RJ. Medicines supply in Africa: should improve through regional collaborations and accredited drug shops. Br Med J. 2005;331:709–710
  12. Rahman S, Smith DK. Use of location allocation models in health services development in developing nations. Eur J Oper Res. 2000;123(3):37–452
  13. Reekie WD. Cartels, spontaneous price discrimination and international pharmaceutical retailing. Int J Econ Bus. 1997;4(3):279–285
  14. Danzon PM. Competition in the off-patent sector: the US experience. Pharma Pricing Rev. 1998;3(3):46–50
  15. Sanley, D., Abdallah, H., Rao, R., Azeez, J. and Garshong, B. (2003). Ghana Pharmaceutical Pricing Study: Policy Analysis and Recommendations. VA: DELIVER. Available at: www.deliver.jsi.com Accessed 08.02.07.
  16. Huff-Rousselle, M. and Sangeeta, R. (2002). Ghana: Estimating the Cost Logistics in the Ministry of Health Supply System. VA: DELIVER. Available at: www.deliver.jsi.com Accessed 08.02.07.
  17. Brumburgh, S. and Sangeeta, R. (2001). Process Mapping: First Step to Reengineering the Health Supply Chain of the Public Sector System. (VA: DELIVER). Available at: www.deliver.jsi.com Accessed 08.02.07.
  18. Alix, B., Quesada, N., Abramson, N., Sanchez, A. and Olson, N. Decentralizing and Integrating Contraceptives Logistics in Latin America and the Caribbean, with Lessons Learned from Asia and Africa. VA: DELIVER for the US Agency for International Development. 2006. Available at: www.deliver.jsi.com Accessed 18.08.07.
  19. Bossert TJ, Bomer DM, Amenyah JK. Is decentralization good for the logistics system? Evidence on essential medicines logistics in Ghana and Guatemala. Health Policy Plan. 2007;22(2):73–82
  20. Summers RS, Moller H, Meyer D, Botha R. “Contracting-Out” Drug Procurement and Distribution: Experience with a Primary-Distributor System in South Africa. Essential Drugs Monitor issue No. 25 & 26 Geneva: WHO; 1998;pp. 10–11
  21. US General Accounting Office . Pharmacy Benefit Program: FEHBP Plans Satisfied with Savings and Services but Retail Pharmacies have Concerns. Washington, DC: GAO/HEHS-97-47; 1997;
  22. Kloos H, Chama T, Abemo D, Tsadik KG, Belay S. Utilization of pharmacies and pharmaceutical drugs in Addis Ababa, Ethiopia. Soc Sci Med. 1986;22(6):653–672
  23. Hukins G, Boyce D. Containing medicines costs in the private sector—the example of a medical benefit scheme. S Afr Med J. 1990;78(3):152–154
  24. Reekie, W.D. (2000). South Africa's battle with HIV/AIDS anddrug prices. National Centre for Policy Analysis No. 334 Available at: www.ncpa.org/∼ncpa/ba/ba334/ba334.pdf. Accessed 19.11.07.
  25. WHO. Effective medicines regulation: ensuring safety, efficacy and quality. WHO/EDM/PAR/2003.2; 2003.
  26. Kaplan WA, Laing R. Paying for pharmaceutical registration in developing countries. Health Policy Plan. 2003;18(3):237–348
  27. WHO. Pharmacovigilance: ensuring the safe use of medicines. WHO/EDM/2002.8; 2002a.
  28. WHO. Traditional medicines: growing needs and potential. WHO/EDM/2002.4; 2002b.
  29. Berman, P. and Bossert, T.J. (2000). A decade of health sectorreform in developing countries: what have we learned? Available at: www.hsph.harvard.edu/ihsg/publications. Accessed 19.08.06.

PII: S1551-7411(08)00064-8

doi: 10.1016/j.sapharm.2008.08.001

Research in Social and Administrative Pharmacy
Volume 5, Issue 3 , Pages 286-297 , September 2009

Article Tools